How Much Does Peptide Therapy Cost? Full 2026 Pricing Guide

Peptide therapy cost varies from about $25/month for an insurance-covered GLP-1 prescription to $1,500+/month for cash-pay GH-axis or stacked protocols. The biggest cost drivers are insurance coverage (or lack of it), brand-name vs compounded medication, and whether you're paying for clinic fees / labs separately or bundled. This article breaks down the typical 2026 pricing across the major peptide-therapy categories.

For the broader context — what peptide therapy is and how to evaluate a clinic — see peptide therapy.

Quick reference table

Category	Monthly cost (cash-pay)	With insurance	Notes
Brand-name GLP-1 (Wegovy / Zepbound)	$1,000–$1,400	$25–$300	Highly plan-dependent
Compounded GLP-1 (where still available)	$250–$500	Usually not covered	Availability tightening since 2024
Oral GLP-1 (Rybelsus, Orforglipron when approved)	$900–$1,200	$25–$300	Same coverage logic as injectable
GH-axis peptide therapy program	$300–$1,500	Rarely covered	Wide range; depends on stack
HGH (FDA-approved, deficiency dx)	$500–$2,000	Usually covered for documented deficiency	Off-label use cash-pay only
BPC-157 / TB-500 / healing peptide course	$200–$800 (one-time course)	Not covered	Compounded; availability narrowed
Sermorelin or Tesamorelin	$250–$800	Tesamorelin covered for HIV lipodystrophy indication	Standard endocrinology
PT-141 (Vyleesi)	$200–$400/dose	Variable	On-demand dosing
Initial clinic consult	$200–$800	Variable	One-time
Baseline labs	$150–$600	Variable	One-time
Follow-up labs (quarterly)	$100–$400 each	Variable	Recurring

What drives the cost

Drug cost

The single largest line item. Three tiers:

1. Brand-name FDA-approved peptide drug, no insurance. US list prices are extreme. Semaglutide (Wegovy) and Tirzepatide (Zepbound) both list around $1,000–$1,400/month. The actual cost to the patient is usually lower via manufacturer discount programs (Novo's WeGoTogether, Lilly's Zepbound savings card), but the unrebated price is the ceiling.
2. Brand-name with insurance coverage. Plan dependent. Some plans cover GLP-1s with a $25 copay; others exclude them entirely; others require BMI ≥ 35 or comorbidity. Coverage has improved through 2024–2026 as employers responded to demand.
3. Compounded peptide. A 503A-compliant compounding pharmacy can in some cases prepare a peptide for a specific patient at substantially lower cost than the brand-name. The list of peptides legally compoundable has narrowed sharply since 2023; compounded GLP-1s in particular have been a moving regulatory target. Verify legality at the time of prescription.

Clinic fees

Three models:

• Membership / subscription. A flat monthly fee ($150–$500) covers consults, follow-up, sometimes labs. Drug cost is separate. Common in telehealth weight-loss clinics.
• Per-visit fee-for-service. Initial $200–$800, follow-ups $100–$300 each. More traditional.
• All-in bundled program. One number covers consults, drug, and labs. $500–$1,500/month range. Convenient but harder to compare cost-per-component across clinics.

Labs

Baseline panels run $150–$600 cash-pay; less with insurance. Follow-up panels typically $100–$400 each, run quarterly to twice yearly depending on protocol. The all-in programs usually bundle labs; pay attention to whether the program excludes lab cost or includes only a basic panel.

Sourcing risk premium (invisible)

Research-use peptides bought outside a clinical channel are cheaper sticker-price but carry product-quality risk (under-dosed product, endotoxin contamination, wrong peptide). The "cost" of that risk shows up as wasted cycles, side effects, and reputation-damaged outcomes. See are peptides safe? for the full discussion.

Worked examples

Example 1 — GLP-1 weight loss with employer insurance

• Drug (Tirzepatide / Zepbound): $50 copay/month.
• Clinic (telehealth, subscription): $150/month.
• Initial labs: $50 copay.
• Quarterly follow-up labs: $50 copay × 4/year = $200/year.

Annual total: ($50 + $150) × 12 + $50 + $200 = $2,650/year.

Example 2 — GLP-1 weight loss, cash pay (no insurance coverage)

• Drug (Tirzepatide brand-name): $1,000/month (with manufacturer discount card).
• Clinic (telehealth, subscription): $200/month.
• Initial labs: $300.
• Quarterly follow-up labs: $200 × 4/year = $800.

Annual total: ($1,000 + $200) × 12 + $300 + $800 = $15,500/year.

Example 3 — GH-axis peptide program (CJC-1295 + Ipamorelin, 12-week cycle)

• Drug (compounded peptide stack): $400/month.
• Clinic (specialty endocrinology, fee-for-service): initial $500 + 3 follow-ups at $200 = $1,100 total.
• Labs (baseline + 12-week): $400 baseline + $300 follow-up = $700.

Cycle total (3 months): ($400 × 3) + $1,100 + $700 = $3,000 for the 12-week cycle.

Example 4 — Acute injury healing (BPC-157, 6-week course)

• Drug (compounded BPC-157, where legally available): $200–$400 for the 6-week course.
• Clinic (specialty practice, fee-for-service): $400 initial consult.
• Labs: usually minimal for this indication; CMP $100.

Course total: $700–$900.

Ways the cost gets lower

• Insurance with GLP-1 coverage — biggest single lever. If your employer plan covers Tirzepatide / Zepbound with a meaningful copay, take it.
• Manufacturer discount programs — Novo's WeGoTogether and Lilly's Zepbound savings card cut cash-pay sticker by $100–$300/month for eligible patients.
• Specialty pharmacy direct programs — some manufacturers run direct-to-patient programs for those without insurance.
• HSA / FSA dollars — peptide therapy that's part of a treatment plan is generally eligible.

Ways the cost gets higher (and unexpectedly)

• Brand switch costs — switching from Tirzepatide to Retatrutide when it approves will reset your insurance step-therapy clock.
• Lab-frequency creep — some programs add monthly labs that compound quickly.
• Stack proliferation — adding a second peptide to "boost" outcomes doubles the cost without doubling the effect.
• Replacing supply lost to compounding-rule changes — the FDA's 503A list has tightened multiple times since 2023; protocols built on compounded peptides have repeatedly had to switch to brand-name (expensive) or stop.

Insurance coverage realities (US, mid-2026)

• GLP-1 for type 2 diabetes — broadly covered.
• GLP-1 for obesity (BMI ≥ 30) — increasingly covered by employer plans; varies sharply by employer.
• GLP-1 for overweight (BMI 27–30 with comorbidity) — variable.
• HGH for diagnosed GH deficiency — generally covered.
• HGH off-label — never covered.
• PT-141 for HSDD — variable; some plans cover Vyleesi.
• Tesamorelin for HIV lipodystrophy — generally covered.
• All research-use peptides (BPC-157, Ipamorelin, etc.) — never covered.

The realistic budget question

If you're trying to set a realistic budget for a 12-month peptide therapy program:

• GLP-1, insurance-covered: $2,000–$5,000/year.
• GLP-1, no insurance coverage: $12,000–$18,000/year.
• GH-axis cycle, twice yearly: $5,000–$8,000/year.
• Targeted healing protocol (one course): $700–$1,500 one-time.

The budget compounds quickly when you stack categories. A patient on Tirzepatide + an Ipamorelin/CJC-1295 cycle + occasional BPC-157 for a sports injury, all cash-pay, can clear $20,000/year.

Where to go from here

• See peptide therapy for what peptide therapy is and how to evaluate a clinic.
• See peptides for weight loss for the per-drug clinical evidence.
• See the per-peptide research profiles in the library.
• Get the safety frame: are peptides safe?, peptide side effects.

PeptidesDB does not sell, prescribe, or refer to specific clinics. This is informational, not medical advice. Pricing was researched in mid-2026 and shifts continuously — verify with your specific clinic and pharmacy at the time of decision.